Video modal
popup modal
The MHICC is now Seriant !
The Montreal Health Innovations Coordinating Center (MHICC) is now Seriant.
Our new name reflects a bold step forward— expanding beyond cardiology and embracing innovations in clinical trials with a global reach.
While our identity has evolved, our commitment to operational excellence, client satisfaction, and quality remains the same.
Unlocking Financial and Operational Efficiencies in Clinical Trials: Modern Competitive Advantages in 2025
November 10, 2025
Clinical trials face unprecedented pressure to balance scientific rigor with cost and operational complexity. This white paper explores how Canada’s predictable regulatory timelines, robust infrastructure, and generous tax incentives create a unique environment to reduce risk and extend operational runways.
Featured insights:
- Optimizing clinical trial costs and operations through strategic country and site selection
- Operational benefits of Montreal’s research ecosystem
- Overview of Canada's refundable R&D tax incentive programs
- Financial case scenarios illustrating Canadian cost advantages versus U.S. trials
- Leveraging the best of decentralized and hybrid trial advantages with expert CRO support
Seriant's funding ecosystem provides clinical trial sponsors competitive financial advantages.
⬇️ Learn how smarter operational strategies and Canada’s funding ecosystem can unlock new competitive advantages for your clinical trial portfolio — Download now.
